COUNTY HALL | LONDON | 20 April, 2023
You are currently logged out. For instant login, click the Request Access button and enter your email address:
WHY ATTEND?
MEET decision makers at leading and upcoming drug discovery and technology companies from the UK and Nordic regions, and investment firms throughout Europe.
LEARN from major investment firms about the current status of European investment in life science technologies.
GAIN insights from experienced life science operators within the Anglo-Nordic space.
Anglonordic has a 20-year tradition as an invitation-only gathering of investors and R&D growth companies that consistently offers unique opportunities for funding and collaboration.
250+ Attendees
70+ Investor Firms
300+ Partnering Meetings
24 Startup Pitches
WHO WILL YOU MEET?
Exclusively selected attendees will represent the following key drivers of the European life sciences growth sector:
- CEOs, CSOs and Heads of Business Development from Emerging Life Science Companies in the Anglo-Nordic sphere and Continental Europe
- Decision-makers from Europe's key Investor firms and Pharma companies
- Key Supporters of the Life Science Ecosystem in Europe
Our 2022 event attracted an amazing total of 71 investment firms, with interests in a wide variety of technologies from small molecule discovery through protein technologies to AI applications and healthcare devices.
The following 55 investment firms have already signed up for Anglonordic 2023:
4BIO Capital, Abingworth, Apposite Capital, Astellas Pharma Europe, Atlas Capital Markets, ATP, Axilium, Cambrian Capital, Catalio Capital, Cathay Capital, Cell and Gene Therapy Catapult, DeBere Capital Partners, Delin Ventures, Eli Lilly and Company, Epidarex, Forbion, Future Planet Capital, GGS Associates, GIMV, GL Investment, Global Brain, Global Entrepeneurs Programme, Hermes Partners Intl. Ltd., Hoxton Ventures, i2020 Accelerator, ICG, Ignite Capital Partners, Inc.Illumina for Startups/Illumina Accelerator, Industrifonden, Inkef, Intermediate Capital Group (ICG), IPF Partners, Kreos Capital, LundbeckFonden BioCapital, M Ventures, Meltwind, MIG Fonds, Monograph Capital, NG Bio Ltd, Norgine Ventures, Novo Holdings, o2h Ventures, Ovata Capital, Oxford Science Enterprise, Primavera Capital Group, Rosetta Capital, Ruffena Capital, Sound Bioventures, Science Creates Ventures, Sofinnova Partners, Sound Bioventures, Start Codon, Sunstone Life Science Ventures, Syncona, UCB Ventures
Welcome to the Anglonordic Life Science Conference. Use the navigation buttons below, or the menu bars above, to access the Programme and Partnering areas.
Anglonordic Life Science Conference Partnering is generously sponsored by Scantox
